You are here

gene therapy

Value-based pricing for gene therapy? Maybe not ready for hemophilia

Value-based pricing for gene therapy? Maybe not ready for hemophilia

Biopharma Dive

valoctocogene roxaparvovec

Flag link:

Hopkins team invents non-viral system for getting gene therapy into cells

Hopkins team invents non-viral system for getting gene therapy into cells

Fierce Biotech

Flag link:

Limelight Bio emerges with $75m to develop next generation gene therapies to overcome limitations of current treatments

Limelight Bio emerges with $75m to develop next generation gene therapies to overcome limitations of current treatments

Pharmaceutical Business Review

Flag link:

FerGene’s Bladder Cancer Phase III Trial Hits Its Mark

FerGene’s Bladder Cancer Phase III Trial Hits Its Mark

BioSpace

Ferring Pharmaceuticals

Blackstone Life Sciences

clinical trials

Flag link:

Here's Why BioMarin Pharmaceutical Leapt 10.2% in November

Here's Why BioMarin Pharmaceutical Leapt 10.2% in November

Motley Fool

Flag link:

Gene Therapy M&A Appetite Provides Lift After Audentes Deal

Gene Therapy M&A Appetite Provides Lift After Audentes Deal

Yahoo/Bloomberg

Audentes Therapeutics

Medicines Company

Flag link:

Merck's Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Merck's Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Fierce Pharma

nadofaragene firadenovec

Flag link:

Japan's Astellas to buy Audentes for $3 billion in gene therapy push

Japan's Astellas to buy Audentes for $3 billion in gene therapy push

Reuters

Audentes Therapeutics

Flag link:

3 Soaring Biotech Stocks to Watch in December

3 Soaring Biotech Stocks to Watch in December

Motley Fool

Arrowhead Pharmaceuticals

Adverum Biotechnologies

Flag link:

Novartis opens new cell and gene therapies facility in Switzerland

Novartis opens new cell and gene therapies facility in Switzerland

Pharmaceutical Business Review

Flag link:

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Reuters

drug manufacturing

PTC Therapeutics

Krystal Biotech

Flag link:

2 Small-Cap Biotechs That Soared Last Week

2 Small-Cap Biotechs That Soared Last Week

Motley Fool

Magenta Therapeutics

Molecular Templates

Flag link:

$50M cell and viral vector manufacturing operation backed by Harvard

$50M cell and viral vector manufacturing operation backed by Harvard

Fierce Pharma

Flag link:

Ferring, Blackstone spin out gene therapy with $570M in funding

Ferring, Blackstone spin out gene therapy with $570M in funding

Fierce Biotech

nadofaragene firadenovec

Blackstone Life Science

bladder cancers

Flag link:

Takeda sees cell, gene therapy in its future. Is it too late?

Takeda sees cell, gene therapy in its future. Is it too late?

Biopharma Dive

Flag link:

ICER draws new gene therapy pricing framework

ICER draws new gene therapy pricing framework

Biopharma Dive

Flag link:

Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity

Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity

Stat

Solid Biosciences

Duchenne Muscular Dystrophy

clinical trials

Flag link:

Regenxbio sues FDA over gene therapy clinical hold

Regenxbio sues FDA over gene therapy clinical hold

Fierce Biotech

clinical trials

Flag link:

Pfizer's 'brainstorming' payment deals as gene therapies advance

Pfizer's 'brainstorming' payment deals as gene therapies advance

Fierce Pharma

outcomes-based pricing

Flag link:

How Prime Solves CRISPR’s Big Problem

How Prime Solves CRISPR’s Big Problem

BioSpace

Flag link:

Pages